Literature DB >> 21859472

Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases.

Justin S Gundara1, Raul Alvarado-Bachmann, Nicholas Williams, Sivakumar Gananadha, Anthony Gill, Thomas J Hugh, Jaswinder S Samra.   

Abstract

Pancreatic neuroendocrine tumours (pNETs) are rare and surgical resection offers the only possibility of cure for localised disease. The role of surgery in the setting of locally advanced and metastatic disease is more controversial. Emerging data suggests that synchronous surgical resection of pancreas and liver may be associated with increased survival. We report two cases of synchronous, one stage multivisceral resections for pNET and associated reconstruction. We highlight the technical issues involved in such extensive resections and demonstrate that one stage multivisceral operations can be achieved safely.

Entities:  

Mesh:

Year:  2011        PMID: 21859472      PMCID: PMC3175454          DOI: 10.1186/1477-7819-9-93

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  18 in total

1.  A technique for the exposure of the third and fourth portions of the duodenum.

Authors:  R B CATTELL; J W BRAASCH
Journal:  Surg Gynecol Obstet       Date:  1960-09

2.  Well-differentiated pancreatic nonfunctioning tumors/carcinoma.

Authors:  Massimo Falconi; Ursula Plockinger; Dik J Kwekkeboom; Riccardo Manfredi; Meike Korner; Larry Kvols; Ulrich F Pape; Jens Ricke; Peter E Goretzki; Stefan Wildi; Thomas Steinmuller; Kjell Oberg; Jean-Yves Scoazec
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

3.  Islet cell carcinomas of the pancreas: a twenty-year experience.

Authors:  G B Thompson; J A van Heerden; C S Grant; J A Carney; D M Ilstrup
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

4.  Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients.

Authors:  C C Solorzano; J E Lee; P W Pisters; J N Vauthey; G D Ayers; M E Jean; R F Gagel; J A Ajani; R A Wolff; D B Evans
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

5.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Authors:  Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

6.  Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report.

Authors:  Y P Le Treut; E Grégoire; J Belghiti; O Boillot; O Soubrane; G Mantion; D Cherqui; D Castaing; P Ruszniewski; P Wolf; F Paye; E Salame; F Muscari; F R Pruvot; J Baulieux
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

7.  Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Authors:  T R Halfdanarson; K G Rabe; J Rubin; G M Petersen
Journal:  Ann Oncol       Date:  2008-05-30       Impact factor: 32.976

8.  Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

Authors:  H Chen; J M Hardacre; A Uzar; J L Cameron; M A Choti
Journal:  J Am Coll Surg       Date:  1998-07       Impact factor: 6.113

9.  Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients.

Authors:  Karl Y Bilimoria; James S Tomlinson; Ryan P Merkow; Andrew K Stewart; Clifford Y Ko; Mark S Talamonti; David J Bentrem
Journal:  J Gastrointest Surg       Date:  2007-09-11       Impact factor: 3.452

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  3 in total

1.  Extensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.

Authors:  Vyacheslav Ivanovich Egorov; Alexander Felixovich Kharazov; Alla Ivanovna Pavlovskaya; Roman Valeryevich Petrov; Natalia Sergeevna Starostina; Eugeny Valerievich Kondratiev; Ekaterina Mikhailovna Filippova
Journal:  World J Gastrointest Surg       Date:  2012-10-27

Review 2.  Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement.

Authors:  Amy Y Li; Brendan C Visser; Monica M Dua
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

Review 3.  Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors.

Authors:  Sven-Petter Haugvik; Knut Jørgen Labori; Anne Waage; Pål-Dag Line; Øystein Mathisen; Ivar Prydz Gladhaug
Journal:  J Gastrointest Surg       Date:  2013-05-14       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.